Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1909 of 6351
-
New hope for Hard-to-Treat lung cancer: targeted drug shows promise in early trial
Disease control OngoingThis is a Phase 1b, open-label, multi-center, dose-escalation and dose expansion study designed to evaluate the safety, pharmacokinetics (PK), and preliminary antitumor activity of furmonertinib in patients with advanced or metastatic non-small cell lung cancer (NSCLC) with activ…
Phase 1 • Sponsor: ArriVent BioPharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New eye injection could mean fewer doctor visits for wet AMD patients
Disease control CompletedThis is a phase 2 randomized, double -masked study comparing the efficacy of EYP-1901 at 2 dose levels: 2060 microgram (mcg) and 3090 mcg against aflibercept.
Phase 2 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Early diet coaching may cut gestational diabetes risk in at-risk moms
Prevention OngoingHealthy eating during pregnancy has favorable effects on markers related to diabetes (glucose tolerance) and is associated with lower gestational diabetes mellitus (GDM) risk. The cornerstone of GDM treatment is nutrition therapy but the latter often starts late in pregnancy and …
Sponsor: CHU de Quebec-Universite Laval • Aim: Prevention
Last updated Jun 26, 2026 14:59 UTC
-
New eye drop could stop pterygium growth without surgery
Disease control OngoingThe objective is to evaluate the safety and efficacy of low dose and high dose CBT-001 eye drop dosed twice daily for 24 months compared to vehicle in reducing conjunctival hyperemia and preventing pterygium progression in eyes with pterygia.
Phase 3 • Sponsor: Cloudbreak Therapeutics, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New inhaled sedative could change ICU care
Symptom relief CompletedThis is a study to compare safety and efficacy of inhaled isoflurane administered via the Sedaconda ACD-S device system versus intravenous propofol for sedation of mechanically ventilated patients in the Intensive Care Unit (ICU) setting.
Phase 3 • Sponsor: Sedana Medical • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Shorter radiation shows promise for prostate cancer control
Disease control CompletedThe aim of the study is 1. Statistical evaluation of patients' characteristics who have intermediate \& high risk localized prostate cancer. 2. Statistical analysis of treatment efficacy of combined hormonal therapy \& hypo fractionated intensity modulated radiotherapy compared …
Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a 60-year-old diet pill work for years? new study aims to find out.
Disease control OngoingThe purpose of this research study is to understand the long-term effects of the drug phentermine on weight, blood pressure, other health outcomes, and safety. Phentermine has been approved by the US Food and Drug Administration (FDA) for weight management since 1959, but it has …
Phase 4 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can a global patient registry unlock the mysteries of Wilson's disease?
Knowledge-focused Recruiting nowLongitudinal, observational, non-interventional, standard of care Registry. Data will be collected from the routinely scheduled WD clinic visits at approximately 6-12 month intervals. At enrolment, in addition to data from the clinic visit, retrospective data will be collected fr…
Sponsor: Orphalan • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
New pill shows promise for Hard-to-Treat blood cancer
Disease control OngoingThis phase I/II trial studies the best dose, possible benefits and/or side effects of oral azacitidine in treating patients with T-cell large granular lymphocytic leukemia that has come back (relapsed) or has not responded to previous treatment (refractory). Chemotherapy drugs, s…
Phase 1/2 • Sponsor: Jonathan Brammer • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Real-World data shows avelumab helps control advanced bladder cancer after chemo
Disease control CompletedThe purpose of this clinical trial is to learn about the safety and effects of the study medicine (called Avelumab) in people with advanced urothelial (bladder) cancer (UC) whose disease hasn't worsened after receiving chemotherapy. This study is seeking participants who: 1. Ha…
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug shows promise for Hard-to-Treat cancers in early trial
Disease control OngoingThe primary purpose of this study is to characterize the safety and tolerability of tucatinib (MK-7119) in Chinese participants with human epidermal growth factor receptor 2 positive (HER2+) advanced breast cancer, gastric or gastroesophageal junction adenocarcinoma (GEC), and co…
Phase 1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can a daily antibiotic keep kids with leukemia safer from infection?
Disease control OngoingCiproPAL is a randomised trial comparing daily ciprofloxacin with local standard care during the induction phase of paediatric ALL treatment, and aims: 1. To assess the efficacy of ciprofloxacin prophylaxis in the reduction of infection during the induction phase of treatment fo…
Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New drug combo shows promise for Hard-to-Treat lymphoma
Disease control OngoingThis phase I/II trial studies the side effects, best dose, and effectiveness of copanlisib and venetoclax in treating patients with mantle cell lymphoma that has come back (relapsed) or does not respond to treatment (refractory). Copanlisib may stop the growth of cancer cells by …
Phase 1/2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New asthma drug shows promise in real-world greek study
Disease control CompletedSevere eosinophilic asthma (SEA) is associated with poor disease control and compromised health-related quality of life (HRQoL), leading to a substantial psychosocial and economic disease burden. Benralizumab (Fasenra®), an interleukin (IL)-5-alpha receptor monoclonal antibody, i…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New shot could tame stubborn hives that antihistamines Can't stop
Disease control CompletedThe purpose of this study is to assess the clinical effect, the pharmacodynamics, the safety, and the pharmacokinetics of barzolvolimab (CDX-0159) in patients with Chronic Inducible Urticaria who remain symptomatic despite the use of H1-antihistamines.
Phase 2 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Video games tested as depression treatment in large study
Symptom relief CompletedThe purpose of the study is to evaluate the effects of a game-based digital-therapeutics (DTx) medical software device on the symptoms of depression in adults with confirmed major depressive disorder.
Sponsor: Aalto University • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New shot could shrink enlarged livers and ease pain
Disease control OngoingThe purpose of the trial is to compare the effectiveness and safety of 2 treatment regimens of CAM2029 (given weekly or every 2 weeks) to placebo in participants with symptomatic PLD, either isolated as in autosomal dominant PLD (ADPLD) or associated with autosomal dominant polyc…
Phase 2/3 • Sponsor: Camurus AB • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a simple drug cut dangerous blood pressure swings in liver transplants?
Disease control OngoingThe purpose of this study is to determine the efficacy and safety of Angiotensin II as a second-line vasopressor (drug that raises the blood pressure) during liver transplantation.
Phase 2/3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could a gentle zap to the ear supercharge OCD treatment?
Symptom relief Recruiting nowIn the proposed investigation, the investigator will develop pilot data for the use of tVNS (transcutaneous vagal nerve stimulation) to enhance efficacy of exposure and response prevention therapy (ERP) to improve treatment success in patients with OCD. This data will include tol…
Sponsor: University of Florida • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
New drug aims to ease daily misery of rare mast cell disease
Symptom relief OngoingThis is a multi-part, randomized, double-blind, placebo-controlled Phase 2 clinical study comparing the safety and efficacy of bezuclastinib (CGT9486) plus best supportive care (BSC) with placebo plus BSC in patients with nonadvanced systemic mastocytosis (NonAdvSM), including in…
Phase 2 • Sponsor: Cogent Biosciences, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC